Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor

Jennifer Huang1, Kim Trinkaus, Charles B Huddleston

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Washington University, St. Louis, Missouri, USA.

Insights

Primary graft failure is a major risk after pediatric heart transplants. Identifying high-risk donors and recipients, including those with congenital heart disease, can improve transplant outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Pediatric Surgery

Background:

  • Primary graft failure is a critical complication following pediatric cardiac transplantation.
  • It is the leading cause of mortality in infant heart transplant recipients.
  • Risk factors contributing to primary graft failure in children remain incompletely understood.

Purpose of the Study:

  • To identify and characterize the risk factors associated with primary graft failure in pediatric cardiac transplantation.
  • To analyze donor, procedural, and recipient variables influencing early graft dysfunction.

Main Methods:

  • Retrospective review of 165 pediatric cardiac transplant recipients.
  • Multivariable logistic regression analysis to assess risk factors.
  • Definition of primary graft failure included need for mechanical circulatory support or intensive inotropic/pressor support within 24 hours post-transplant.

Main Results:

  • Primary graft failure occurred in 33% of patients; 15% required mechanical support.
  • Recipient factors: congenital heart disease and pre-transplant mechanical support increased risk.
  • Donor factors: increased donor-recipient size ratio, longer ischemic time, anoxia, and CPR time were associated with higher risk.
  • Donor blood type O+ and hyperdynamic systolic function were protective.

Conclusions:

  • Numerous donor, recipient, and procedural factors are linked to primary graft failure in pediatric heart transplantation.
  • Recipient's pre-existing heart condition severity is a significant risk factor.
  • Optimizing donor-recipient matching by avoiding high-risk pairings may reduce post-transplant morbidity and mortality.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...